Toxic erythema of chemotherapy: A useful clinical term

Journal of the American Academy of Dermatology

Volumn 59, Issue 3, 2008, Pages 524-529

  Bolognia, Jean L ^a   Cooper, Dennis L ^b   Glusac, Earl J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BLEOMYCIN; BUSULFAN; CAPECITABINE; CARBOPLATIN; CARMUSTINE; CELECOXIB; CISPLATIN; CLOFARABINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; DIMETHYL SULFOXIDE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; HYDROXYUREA; IFOSFAMIDE; LOMUSTINE; MERCAPTOPURINE; METHOTREXATE; MITOTANE; PACLITAXEL; PYRIDOXINE; THIOTEPA; UNINDEXED DRUG;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALOPECIA; BONE MARROW SUPPRESSION; CARDIOTOXICITY; CLINICAL FEATURE; COMPRESSION GARMENT; CONTINUOUS INFUSION; CRYOTHERAPY; DESQUAMATION; DIAGNOSTIC ERROR; DISEASE SEVERITY; DISTAL PARESTHESIA; DRUG MEGADOSE; EDITORIAL; ERYTHEMA; GRAFT VERSUS HOST REACTION; HAND FOOT SYNDROME; HIDRADENITIS; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JOINT SWELLING; MUCOSA INFLAMMATION; PATHOPHYSIOLOGY; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; TOXIC ERYTHEMA OF CHEMOTHERAPY;

ACRODERMATITIS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; ECCRINE GLANDS; EPIDERMIS; ERYTHEMA; HIDRADENITIS; HUMANS; PARESTHESIA; SKIN; TERMINOLOGY AS TOPIC;

EID: 48749117172     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.05.018     Document Type: Editorial

References (53)

1. Levine L.E., Medenica M.M., Lorincz A.L., Soltani K., Raab B., and Ma A. Distinctive acral erythema occurring during therapy for severe myelogenous leukemia. Arch Dermatol 121 (1985) 102-104
2. Krulder J.W.M., Vlasveld L.T., and Willemze R. Erythema and swelling of the ears after treatment with cytarabine for leukemia. Eur J Cancer 26 (1990) 649-650
3. Azurdia R.M., Clark R.E., and Friedmann P.S. Chemotherapy-induced acral erythema (CIAE) with bullous reaction. Clin Exp Dermatol 24 (1999) 64-66
4. Waltzer J.F., and Flowers F.P. Bullous variant of chemotherapy-induced acral erythema. Arch Dermatol 129 (1993) 43-45
5. Demircay Z., Gürbüz O., Alpdogan T.B., Yücelten D., Alpdogan O., Kurtkaya O., et al. Chemotherapy-induced acral erythema in leukemic patients: a report of 15 cases. Int J Dermatol 36 (1997) 593-598
6. Alonso V., Ramón, Monteagudo C., Llombart B., Martín J.M., García L., et al. Eccrine squamous syringometaplasia mimicking a herpetic infection. Int J Dermatol 45 (2006) 762-763
7. Zuehlke R.L. Erythematous eruption of the palms and soles associated with mitotane therapy. Dermatologica 148 (1974) 90-92
8. Burgdorf W.H.C., Gilmore W.A., and Ganick R.G. Peculiar acral erythema secondary to high-dose chemotherapy for acute myelogenous leukemia. Ann Intern Med 97 (1982) 61-62
9. Herzig R.H., Wolff S.N., Lazarus H.M., Phillips G.L., Karanes P.C., and Herzig G.P. High-dose cytosine arabinoside therapy for refractory leukemia. Blood 622 (1983) 361-369
10. Cordonnier C., Roujeau J.C., Vernant J.P., Matheron S., and Ganem G. Cancer chemotherapy and acral erythema. Ann Intern Med 97 (1982) 783-784
11. Lokich J., Fine N., Perri J., and Bothe Jr. A. Protracted ambulatory venous infusion of 5-fluorouracil. Am J Clin Oncol 6 (1983) 103-107
12. Silver F.S., Espinoza L.R., and Hartmann R.C. Acral erythema and hydroxyurea. Ann Intern Med 98 (1983) 675
13. Doyle L.A., Berg C., Bottino G., and Chabner B. Erythema and desquamation after high-dose methotrexate. Ann Intern Med 98 (1983) 611-612
14. Walker I.R., Wilson W.E.C., Sauder D.N., Benger A.M., and Browman G. Cytarabine-induced palmar-plantar erythema. Arch Dermatol 121 (1985) 1240-1241
15. Feldman L.D., and Ajani J.A. Fluorouracil-associated dermatitis of the hands and feet. JAMA 254 (1985) 3479
16. Crider M.K., Jansen J., Norins A.L., and McHale M.S. Chemotherapy-induced acral erythema in patients receiving bone marrow transplantation. Arch Dermatol 122 (1986) 1023-1027
17. Cox G.J., and Robertson D.B. Toxic erythema of palms and soles associated with high-dose mercaptopurine chemotherapy. Arch Dermatol 122 (1986) 1413-1414
18. Lokich J.J., and Moore C. Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome. Ann Intern Med 101 (1984) 798-800
19. Bhawan J., and Malhotra R. Syringosquamous metaplasia. A distinctive eruption in patients receiving chemotherapy. Am J Dermatopathol 12 (1990) 1-6
20. Brazzelli V., Ardigo M., Chiesa M.G., Vassallo C., Varettoni M., Borroni R.G., et al. Flexural erythematous eruption following autologous peripheral blood stem cell transplantation; a study of four cases. Br J Dermatol 145 (2001) 490-495
21. Campanelli A., Kerl K., and Lübbe J. Severe palmoplantar erythrodysesthesia and intertrigolike eruption induced by polyethylene glycol-coated liposomal doxorubicin. J Eur Acad Dermatol Venereol 20 (2006) 1022-1024
22. Hurt M.A., Halvorson R.D., Petr Jr. C., Cooper Jr. J.T., and Friedman D.J. Eccrine squamous syringometaplasia. A cutaneous sweat gland reaction in the histologic spectrum of 'chemotherapy-associated eccrine hidradenitis' and 'neutrophilic eccrine hidradenitis.'. Arch Dermatol 126 (1990) 73-77
23. Korver G.E., Harris R., and Petersen M.J. An intertrigo-like eruption from pegylated liposomal doxorubicin. J Drugs Dermatol 5 (2006) 901-902
24. Lotem M., Hubert A., Lyass O., Goldenhersh M.A., Ingber A., Peretz T., et al. Skin toxic effects of polyethylene glycol-coated liposomal doxorubicin. Arch Dermatol 136 (2000) 1475-1480
25. Santa Cruz D.J., Samuels L.E., Bauer E.A., Phillips G.L., and Herzig G.P. Epidermal dystrophy: clinicopathologic study of chemotherapeutic agent toxicity in ten patients. [abstract]. Lab Invest 46 (1982) 72A
26. Valks R., Fraga J., Porras-Luque J., Figuera A., Garcia-Diez A., and Fernandez-Herrera J. Chemotherapy-induced eccrine squamous syringometaplasia: a distinctive eruption in patients receiving hematopoietic progenitor cells. Arch Dermatol 133 (1997) 873-878
27. Webber K.A., Kos L., Holland K.E., Margolis D.A., and Drolet B.A. Intertriginous eruption associated with chemotherapy in pediatric patients. Arch Dermatol 143 (2007) 67-71
28. Burke M.C., Bernhard J.D., and Michelson A.D. Chemotherapy-induced painful acral erythema in childhood: Burgdorf's reaction. Am J Pediatr Hematol Oncol 11 (1989) 44-45
29. English III J.C., Toney R., and Patterson J.W. Intertriginous epidermal dysmaturation from pegylated liposomal doxorubicin. J Cutan Pathol 30 (2003) 591-595
30. Chun Y.-S., Chang S.N., Oh D., and Park W.H. A case of cutaneous reaction to chemotherapeutic agents showing epidermal dysmaturation. J Am Acad Dermatol 43 (2000) 358-360
31. Rongioletti F., Ballestrero A., Bogliolo F., and Rebora A. Necrotizing eccrine squamous syringometaplasia presenting as acral erythema. J Cutan Pathol 18 (1991) 453-456
32. Sheen Y.-S., Huang C.-L., and Chu C.-Y. Eccrine squamous syringometaplasia associated with sunitinib therapy. J Eur Acad Dermatol Venereol 21 (2007) 1136-1137
33. Tsuboi H., Yonemoto K., and Katsuoka K. A case of bleomycin-induced acral erythema (AE) with eccrine squamous syringometaplasia (ESS) and summary of reports of AE with ESS in the literature. J Dermatol 32 (2005) 921-925
34. Flynn T.C., Harrist T.J., Murphy G.F., Loss R.W., and Moschella S.L. Neutrophilic eccrine hidradenitis: a distinctive rash associated with cytarabine therapy and acute leukemia. J Am Acad Dermatol 11 (1984) 584-590
35. Werchniak A.E., Chaffee S., and Dinulos J.G.H. Methotrexate-induced bullous acral erythema in a child. J Am Acad Dermatol 52 (2005) S93-S95
36. Katoh M., Kadota M., and Nishimura Y. A case of docetaxel-induced erythrodysesthesia. J Dermatol 31 (2004) 403-406
37. Ziemer M., Goetze S., Kaatz M., and Elsner P. Chemotherapy-induced toxic erythema under treatment with pegylated liposomal doxorubicin: no restriction to palms and soles. J Am Acad Dermatol 58 suppl 1 (2008) S44-S46
38. Slavin R.E., Dias M.A., and Saral R. Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols. Cancer 42 (1978) 1747-1759
39. Vukelja S.J., Sharkey M.J., Baker W.J., and Berger T.C. Pericarditis associated with acral erythema of chemotherapy: a syndrome of cutaneous and serosal toxicities. Cutis 52 (1993) 89-90
40. O'Brien M.E., Wigler N., Inbar M., Rosso R., Grischke E., Santoro A., et al., CAELYX Breast Cancer Study Group. Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. Ann Oncol 15 (2004) 440-449
41. Horn T.D. Antineoplastic chemotherapy, sweat, and the skin. Arch Dermatol 133 (1997) 905-906
42. Jacobi U., Waibler E., Schulze P., Sehouli J., Oskay-Özeclik G., Schmook T., et al. Release of doxorubicin in sweat: first step to induce the palmar-plantar erythrodysesthesia syndrome?. Ann Oncol 16 (2005) 1210-1211
43. Horn T.D., Beveridge R.A., Egorin M.J., Abeloff M.D., and Hood A.F. Observations and proposed mechanism of N,N′,N″-triethylenethiophosphoramide (thiotepa)-induced hyperpigmentation. Arch Dermatol 125 (1989) 524-527
44. Bhawan J., Petry J., and Rybak M.E. Histologic changes induced in skin by extravasation of doxorubicin (adriamycin). J Cutan Pathol 16 (1989) 158-163
45. Serrano T., Saez A., and Moreno A. Eccrine squamous syringometaplasia. A prospective clinicopathologic study. J Cutan Pathol 20 (1993) 61-65
46. Brown J., Burck K., Black D., and Collins C. Treatment of cytarabine acral erythema with corticosteroids. J Am Acad Dermatol 24 (1991) 1023-1025
47. Kanat O., Baskan B.E., Kurt E., and Evrensel T. Successful treatment of palmar-plantar erythrodysesthesia possibly due to temozolomide with dexamethasone. J Postgrad Med 53 (2007) 146
48. Lopez A.M., Wallace L., Dorr R.T., Koff M., Hersh E.M., and Alberts D.S. Topical DMSO treatment for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia. Cancer Chemother Pharmacol 44 (1999) 303-306
49. Lin E., Morris J.S., and Ayers G.D. Effect of celecoxib on capecitabine-induced hand-foot syndrome and antitumor activity. Oncology 16 suppl (2002) 31-37
50. Fabian C.J., Molina R., Slavik M., Dahlberg S., Giri S., and Stephens R. Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion. Invest New Drugs 8 (1990) 57-63
51. Kara I.O., Sahin B., and Erkisi M. Palmar-plantar erythrodysesthesia due to docetaxel-capecitabine therapy is treated with vitamin E without dose reduction. Breast 15 (2006) 414-424
52. Baack B.R., and Burgdorf W.H.C. Chemotherapy-induced acral erythema. J Am Acad Dermatol 24 (1991) 457-461
53. Greenbaum B.H., Heymann W.R., Reid C.S., Travis S.F., and Donaldson M.H. Chemotherapy-associated eccrine hidradenitis: neutrophilic eccrine hidradenitis reevaluated: the role of neutrophilic infiltration. Med Pediatr Oncol 16 (1988) 351-355